4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000102
Chairperson & CEO sold 9,500 shares at an average $531.69 ($5,051,035)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-20 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-20 | Sale : show line 2 in the form 10b5-1 | −1,831 | $529.19 | $968,945 | 332,112 | I |
| 2026-07-20 | Sale : show line 3 in the form 10b5-1 | −960 | $529.85 | $508,657 | 331,152 | I |
| 2026-07-20 | Sale : show line 4 in the form 10b5-1 | −1,660 | $531.08 | $881,588 | 329,492 | I |
| 2026-07-20 | Sale : show line 5 in the form 10b5-1 | −1,874 | $532.07 | $997,105 | 327,618 | I |
| 2026-07-20 | Sale : show line 6 in the form 10b5-1 | −1,686 | $533.03 | $898,683 | 325,932 | I |
| 2026-07-20 | Sale : show line 7 in the form 10b5-1 | −889 | $534.13 | $474,838 | 325,043 | I |
| 2026-07-20 | Sale : show line 8 in the form 10b5-1 | −520 | $535.20 | $278,306 | 324,523 | I |
| 2026-07-20 | Sale : show line 9 in the form 10b5-1 | −80 | $536.41 | $42,913 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $531.69 · $5,051,035 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-20 | Exercise or conversion : show line 10 in the form 10b5-1 Stock Option | −9,500 | 312,910 | I |
Loading xslF345X06/primarydocument.xml…